Immune protein infusion tested to stop agony of sickle cell crises
NCT ID NCT01757418
Summary
This study tested whether a single dose of an immune protein therapy (IVIG) could safely shorten severe pain crises in people with sickle cell disease. About 300 children and adults were given either IVIG or a placebo saline solution during a hospital stay for a pain crisis. Researchers measured how long the crisis lasted, how much pain medication was needed, and checked for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.